Jiahao Zhou

Mr. Jiahao Zhou

Ruijin Hospital, Shanghai, China
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
XHXumei Hu
Xumei Hu
JZJiahao Zhou
Jiahao Zhou
YLYan Li
Yan Li
YWYikun Wang
Yikun Wang
JGJing Guo
Jing Guo
CWChengyan Wang
Chengyan Wang
This study aimed to explore the added value of viscoelasticity measured by magnetic resonance elastography (MRE) in the prediction of Ki-67 expression in hepatocellular carcinoma (HCC) using a deep learning combined radiomics (DLCR) model. This retrospective study included 108 histopathology-proven HCC patients (93 males; age, 59.6 ± 11.0 years) who underwent preoperative MRI and MR elastography. They were divided into training (n = 87; 61.0 ± 9.8 years) and testing (n = 21; 60.6 ± 10.1 years) cohorts. An independent validation cohort including 43 patients (60.1 ± 11.3 years) was included for testing. A DLCR model was proposed to predict the expression of Ki-67 with cMRI, including T2W, DW, and dynamic contrast enhancement (DCE) images as inputs. The images of the shear wave speed (c-map) and phase angle (φ-map) derived from MRE were also fed into the DLCR model. The Ki-67 expression was classified into low and high groups with a threshold of 20%. Both c and φ values were ranked within the top six features for Ki-67 prediction with random forest selection, which revealed the value of MRE-based viscosity for the assessment of tumor proliferation status in HCC. When comparing the six CNN models, Xception showed the best performance for classifying the Ki-67 expression, with an AUC of 0.80 ± 0.03 (CI: 0.79–0.81) and accuracy of 0.77 ± 0.04 (CI: 0.76–0.78) when cMRI were fed into the model. The model with all modalities (MRE, AFP, and cMRI) as inputs achieved the highest AUC of 0.90 ± 0.03 (CI: 0.89–0.91) in the validation cohort. The same finding was observed in the independent testing cohort, with an AUC of 0.83 ± 0.03 (CI: 0.82–0.84). The shear wave speed and phase angle improved the performance of the DLCR model significantly for Ki-67 prediction, suggesting that MRE-based c and φ-maps can serve as important parameters to assess the tumor proliferation status in HCC.

1 September 2026 in Radiology
Verified
Journal Article
Closed access
QFQiuyi Fu
Qiuyi Fu
YZYufei Zeng
Yufei Zeng
RCRui Chang
Rui Chang
ZXZhihan Xu
Zhihan Xu
YZYing Zhan
Ying Zhan
FYFuhua Yan
Fuhua Yan
Photon-counting CT is comparable to MRI for clinical T categorization and has better diagnostic performance for nodal metastases; however, assessment of microcalcifications is limited compared with mammography.

1 August 2026 in Radiology
Verified
Journal Article
Closed access
XWXinyu Wu
Xinyu Wu
JLJinzhe Li
Jinzhe Li
RDRong Deng
Rong Deng
XXXinxin Xu
Xinxin Xu
JZJiahao Zhou
Jiahao Zhou
HLHuimin Lin
Huimin Lin
Extracellular volume fraction measured with photon-counting CT was used to accurately quantify liver fibrosis and enabled excellent stratification for fibrosis staging equivalent to MR elastography, using histopathologic findings as the reference.

3 August 2023
Verified
Conference Paper
Closed access
XHXumei Hu
Xumei Hu
RLRuokun Li
Ruokun Li
JZJiahao Zhou
Jiahao Zhou
JGJing Guo
Jing Guo
ISIngolf Sack
Ingolf Sack
CWChengyan Wang
Chengyan Wang
In this study, a combined deep learning and radiomics (DLR) approach using six different network architectures was tested and compared for the prediction of high Ki-67 expressions in patients with hepatocellular carcinoma (HCC). The model was based primarily on data from MRI and tomoelastography, a multifrequency MR elastography technique. Xception delivered the best performance and recognized seven prominent features among which four were obtained from tomoelastography. Our findings demonstrated that biomechanical properties, especially viscosity and the fluid behavior of the tumor, are crucial imaging features that are important for imaging-based cancer diagnostics.